Natera Inc (NAS:NTRA)
$ 162.39 0.4 (0.25%) Market Cap: 21.44 Bil Enterprise Value: 20.99 Bil PE Ratio: 0 PB Ratio: 22.95 GF Score: 70/100

Natera Inc at Morgan Stanley Healthcare Conference Transcript

Sep 11, 2019 / 03:40PM GMT
Release Date Price: $30.55 (+1.83%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Okay. Perfect. Well, welcome, everyone. Thanks for coming this afternoon on the final day of the Morgan Stanley Healthcare Conference. Pleased to have with me today Natera CEO, Steve Chapman; and CFO, Mike Brophy. Quickly we have to start. Please note that all important disclosures, including personal holdings discloses and Morgan Stanley disclosures appear on the Morgan Stanley public website at www.morganstanley.com/researchdislosures.

Questions & Answers

Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

So maybe with that, I'll start with you, Steve, just to set the ground a little bit here. Natera historically, originally, was sort of an NIPT reproductive story. The company's certainly pushed deeper into women's health, oncology, transplant in recent years. Maybe for those who aren't as familiar, just spend a little time sort of level setting your

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot